Absence of Pharmacokinetic and Pharmacodynamic Interactions between Almorexant and Warfarin in Healthy Subjects

BACKGROUND AND OBJECTIVE: Almorexant is the first representative of the new class of orexin receptor antagonists, which could become a new treatment option for insomnia. The present study investigated the potential interaction between almorexant and warfarin. METHODS: In this open-label, two-way cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Dingemanse, Jasper, Hoever, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689907/
https://www.ncbi.nlm.nih.gov/pubmed/23737453
http://dx.doi.org/10.1007/s40268-013-0017-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689907/
https://www.ncbi.nlm.nih.gov/pubmed/23737453
http://dx.doi.org/10.1007/s40268-013-0017-5

Ejemplares similares